(Q34372881)

English

Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (English)

1 reference

Europe PubMed Central

1 August 2017

1 reference

based on heuristic

inferred from title

corrigendum / erratum

Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

0 references

author name string

Y Miao

1

1 reference

Europe PubMed Central

1 August 2017

D Dobre

2

1 reference

Europe PubMed Central

1 August 2017

H J Lambers Heerspink

3

1 reference

Europe PubMed Central

1 August 2017

B M Brenner

4

1 reference

Europe PubMed Central

1 August 2017

M E Cooper

5

1 reference

Europe PubMed Central

1 August 2017

H-H Parving

6

1 reference

Europe PubMed Central

1 August 2017

S Shahinfar

7

1 reference

Europe PubMed Central

1 August 2017

D Grobbee

8

1 reference

Europe PubMed Central

1 August 2017

D de Zeeuw

9

1 reference

Europe PubMed Central

1 August 2017

publication date

30 September 2010

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

54

1 reference

Europe PubMed Central

1 August 2017

1

1 reference

Europe PubMed Central

1 August 2017

44-50

1 reference

Europe PubMed Central

1 August 2017

https://scigraph.springernature.com/pub.10.1007/s00125-010-1922-6

0 references

Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

6 July 2018

The frequency of hyperkalemia and its significance in chronic kidney disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

6 July 2018

Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

6 July 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

6 July 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

6 July 2018

Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

27 October 2018

Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

27 October 2018

Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system: balancing risk and benefit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

27 October 2018

Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

27 October 2018

Spurious hyperkalaemia due to EDTA contamination: common and not always easy to identify

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

27 October 2018

Is suboptimal phlebotomy technique impacting on potassium results for primary care?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

27 October 2018

ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

27 October 2018

Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

27 October 2018

Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

27 October 2018

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

27 October 2018

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

27 October 2018

Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

27 October 2018

The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995871

27 October 2018

Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on serum potassium levels and renal function in ambulatory outpatients: risk factors analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20882268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trans-tubular potassium gradient in patients with drug-induced hyperkalemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20882268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of atrial natriuretic peptide on potassium-stimulated aldosterone secretion: potential relevance to hypoaldosteronism in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/20882268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathophysiology of low renin syndromes: sites of renal renin secretory impairment and prorenin overexpression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20882268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating proteinuria in a diabetic patient despite hyperkalaemia due to hyporeninaemic hypoaldosteronism

1 reference

https://pubmed.ncbi.nlm.nih.gov/20882268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20882268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of factors causing hyperkalemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20882268

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-010-1922-6

1 reference

Europe PubMed Central

1 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34372881&oldid=1958146882"